Overview

Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study will evaluate the safety and efficacy of Patupilone in adult patients with advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Epothilone B
Epothilones